Not sure why the big-sell off but today's announcement was great for financials. It will certainly beat Goldman Sachs 2022-23 FY outlook on Revenue and Cashflow. Great work by Gareth and the Core team on negotiating 80% prepayment and shifting favorable impacts to current financial year. My quick calculation tells me we are expecting Cashflow of $100M AUD in the next 2 months. I'm already looking forward to profitable 2022-2023 Annual Report. Well done Core Team.
Reported Revenue/Cashflow Apr - Jun 2023 Customer Sale Qty Price USD Est Revenue USD Recognition Apr-Jun Cashflow USD Cashflow AUD @ 0.7 Yahua 3,500 4500 15,750,000 100% 15,750,000 22,500,000 Yahua 15,000 4500 67,500,000 80% 54,000,000 77,142,857 69,750,000 99,642,857
- Forums
- ASX - By Stock
- Ann: Additional Spodumene Sales Agreements Secured with Yahua
Not sure why the big-sell off but today's announcement was great...
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.8¢ |
Change
-0.007(6.67%) |
Mkt cap ! $210.0M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 9.8¢ | $6.405M | 65.16M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1644860 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 2435187 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1644860 | 0.098 |
5 | 256579 | 0.097 |
4 | 133997 | 0.096 |
33 | 936550 | 0.095 |
1 | 100000 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 2400338 | 22 |
0.110 | 4549634 | 44 |
0.115 | 2915351 | 38 |
0.120 | 5600143 | 54 |
0.125 | 3337190 | 47 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
CXO (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online